Eylea intravitreal injection kit 40mg/mL, manufactured by Bayer Pharmaceutical, contains aflibercept (genetical recombination) and is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and retinopathy of prematurity. This 2mg 0.05mL 1 tube formulation (YJ code: 1319405G1020) works by blocking growth factors to prevent abnormal blood …
Eylea intravitreal injection kit 40mg/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →